Edition:
United Kingdom

Aspen Pharmacare Holdings Ltd (APNJ.J)

APNJ.J on Johannesburg Stock Exchange

10,800.00ZAc
23 Apr 2019
Change (% chg)

-- (--)
Prev Close
10,800.00
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,681,675
52-wk High
29,800.00
52-wk Low
6,899.00

About

Aspen Pharmacare Holdings Limited is a South Africa-based supplier and manufacturer of branded and generic pharmaceutical products, as well as infant nutritional and consumer healthcare products. The Company's segments include International, South Africa, Asia Pacific and Sub-Saharan Africa (SSA). Its International business... (more)

Overall

Beta: 0.56
Market Cap(Mil.): R139,674.20
Shares Outstanding(Mil.): 456.45
Dividend: 287.00
Yield (%): 0.94

Financials

  APNJ.J Industry Sector
P/E (TTM): 27.38 29.30 32.55
EPS (TTM): 11.17 -- --
ROI: 6.19 14.23 13.83
ROE: 11.92 15.46 15.25

UPDATE 1-South Africa's rand recovers after U.S. jobs data, stocks slide on Aspen

JOHANNESBURG, March 8 South Africa's rand firmed on Friday, recovering from a nine-week low after sluggish U.S. employment data pushed the dollar lower and saw demand for emerging markets return.

08 Mar 2019

UPDATE 2-Shares in S.Africa's Aspen plunge on debt, slow sale proceeds

* Debt levels still within creditor threshold (Adds historical debt, details)

08 Mar 2019

Aspen shares plunged by nearly 40 pct on debt worries

JOHANNESBURG, March 8 Shares of South Africa-based drugmaker Aspen Pharmacare plunged nearly 40 percent on Friday, as rising debt worried investors.

08 Mar 2019

UPDATE 1-Aspen to split South African pharma business after disposal of non-core assets

JOHANNESBURG, March 7 Multinational drugmaker Aspen Pharmacare said it will split its South African Commercial Pharmaceuticals business into two divisions as it disposes of non-core assets to reduce its debt.

07 Mar 2019

UPDATE 1-Aspen Pharmacare drops on debt worries and revenue forecast

JOHANNESBURG, Dec 14 Shares in Aspen Pharmacare fell more than 8 percent on Friday, a day after the South African drugmaker said it had negotiated a temporary relaxation of its lending agreements and forecast little growth in full-year revenues.

14 Dec 2018

South Africa's Aspen strikes distribution deal with U.S. drugmaker Mylan

JOHANNESBURG Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.

13 Dec 2018

UPDATE 1-South Africa's Aspen strikes distribution deal with U.S. drugmaker Mylan

JOHANNESBURG, Dec 13 Aspen Pharmacare has struck a deal with U.S. generics maker Mylan to distribute a portfolio of prescription and over-the-counter drugs in Australia and New Zealand.

13 Dec 2018

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

26 Nov 2018

South Africa's Aspen launches three-in-one HIV drug

JOHANNESBURG, Nov 26 South African drugmaker Aspen Pharmacare on Monday launched a triple-combination tablet for the treatment of HIV in the country where the virus is most prevalent.

26 Nov 2018

Kraft to sell Canada natural cheese business to Parmalat

Kraft Heinz Co has agreed to sell its Canadian natural cheese business to Parmalat SpA in a C$1.62 billion ($1.23 billion) deal that will help Kraft trim its debt and extend the North American footprint of Parmalat owner Lactalis.

07 Nov 2018

Earnings vs. Estimates